[ad_1] The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of...
[ad_1] Aachen, Germany, 22 October 2024 – Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a...
[ad_1] ATLANTA, August 29, 2024 (Newswire.com) – The trial in the case of Bernard Bronner vs. Rainforest Films, Will Packer, Rob Hardy, and TRF Productions, LLC...